The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
116414665 11641466 5 F 20160627 20151019 20160705 EXP US-BAYER-2015-441324 BAYER 62.00 YR A F Y 0.00000 20160705 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
116414665 11641466 1 PS NEXAVAR SORAFENIB 1 Oral 200 MG ALTERNATING WITH 400MG (EVERY OTHER DAY) 21923 FILM-COATED TABLET
116414665 11641466 2 SS NEXAVAR SORAFENIB 1 Oral 200 MG ALTERNATING WITH 600 MG (EVERY OTHER DAY) 21923 FILM-COATED TABLET
116414665 11641466 3 SS NEXAVAR SORAFENIB 1 Oral 400MG IN AM AND 200MG IN PM 21923 600 MG FILM-COATED TABLET

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
116414665 11641466 1 Erdheim-Chester disease
116414665 11641466 2 Malignant histiocytosis
116414665 11641466 3 Erdheim-Chester disease

Outcome of event

Event ID CASEID OUTC COD
116414665 11641466 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
116414665 11641466 Acne
116414665 11641466 Blister
116414665 11641466 Contusion
116414665 11641466 Corneal bleeding
116414665 11641466 Cough
116414665 11641466 Dizziness
116414665 11641466 Gastrointestinal injury
116414665 11641466 Gastrooesophageal reflux disease
116414665 11641466 Hair texture abnormal
116414665 11641466 Hypertension
116414665 11641466 Macular oedema
116414665 11641466 Off label use
116414665 11641466 Rash
116414665 11641466 Respiratory tract congestion
116414665 11641466 Skin lesion

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
116414665 11641466 3 20150113 0